In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.57 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level of $2.20 trading at $0.05 or 2.33% at ring of the bell on the day assigns it a market valuation of $135.56M. That closing price of PROK’s stock is at a discount of -514.09% from its 52-week high price of $13.51 and is indicating a premium of 49.09% from its 52-week low price of $1.12. Taking a look at company’s average trading volume volume of 741.09K if we extend that period to 3-months.

ProKidney Corp (NASDAQ:PROK) trade information

Upright in the green during last session for gaining 2.33%, in the last five days PROK remained trading in the green while hitting it’s week-highest on Monday, 04/29/24 when the stock touched $2.20 price level, adding 10.57% to its value on the day. ProKidney Corp’s shares saw a change of 23.60% in year-to-date performance and have moved 3.77% in past 5-day. ProKidney Corp (NASDAQ:PROK) showed a performance of 52.78% in past 30-days.

ProKidney Corp (PROK) estimates and forecasts

Statistics highlight that ProKidney Corp is scoring comparatively lower than the scores of other players of the relevant industry. The company added 32.13% of value to its shares in past 6 months, showing an annual growth rate of -14.04% while that of industry is 11.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

PROK Dividends

ProKidney Corp is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.